...
首页> 外文期刊>British Journal of Haematology >Expression of the novel tumour suppressor sterile alpha motif and HD domain-containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma
【24h】

Expression of the novel tumour suppressor sterile alpha motif and HD domain-containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma

机译:新型肿瘤抑制性无菌α基序和高清域蛋白1的表达是典型霍奇金淋巴瘤中的独立不良预后因素

获取原文
获取原文并翻译 | 示例
           

摘要

The expression patterns and prognostic significance of sterile alpha motif and HD domain-containing protein 1 (SAMHD1) protein in the neoplastic Hodgkin and Reed Sternberg (HRS) cells of Hodgkin lymphoma (HL) were investigated in a cohort of 154 patients with HL treated with standard regimens. SAMHD1 expression was assessed by immunohistochemistry using diagnostic lymph node biopsies obtained prior to treatment. Using an arbitrary 20% cut-off, SAMHD1 was positive in HRS cells of 48/154 (31.2%) patients. SAMHD1 expression was not associated with clinicopathologic parameters, such as age, gender, stage or histologic subtype. In 125 patients with a median follow-up of 90 months (7-401 months), SAMHD1 expression in HRS cells significantly correlated with inferior freedom from progression (FFP) (P = 0.025), disease-specific survival (DSS) (P = 0.013) and overall survival (OS) (P = 0.01). Importantly, in multivariate models together with disease stage, histology subtype and type of treatment as covariates, SAMHD1 expression retained an independent significant association with unfavourable FFP (P = 0.005) as well as DSS (P = 0.022) and OS (P = 0.018). These findings uncover the significance of a novel, adverse prognostic factor in HL that may have therapeutic implications since SAMHD1 inhibitors are now available for clinical use.
机译:在154例HL处理的患者中,研究了肿瘤霍奇金菌和芦苇术(HL)的肿瘤霍格金和芦苇斯特氏菌(HRS)细胞中的无菌α基序和HD结构域蛋白1(Samhd1)细胞的表达模式和预后意义。标准方案。 SAMHD1表达通过免疫组织化学评估使用在处理之前获得的诊断淋巴结活组织检查。使用任意20%的截止,SamHD1在48/154(31.2%)患者的HRS细胞中为阳性。 Samhd1表达与临床病理参数无关,例如年龄,性别,阶段或组织学亚型。在125名患者中位60个月(7-401个月),HRS细胞中的Samhd1表达与来自进展(FFP)的自由度显着相关(P = 0.025),疾病特异性存活(DSS)(P = 0.013)和总存活(OS)(P = 0.01)。重要的是,在多变量模型与疾病阶段,组织学亚型和治疗类型作为协变量中,SAMHD1表达与不利的FFP(P = 0.005)以及DSS(P = 0.018)保留独立的显着关系(P = 0.018) 。这些发现发现了一种新颖,其具有治疗意义的HL的重要性,因为现在SAMHD1抑制剂现在可用于临床用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号